Panacea Biotec recieves EIR for its company's Oncology Parenteral and Oral Solids Dosage formulations facility in Baddi

From USFDA

Panacea Biotec has received Establishment Inspection Report (EIR) from USFDA indicating formal closure of the cGMP and pre-approval inspection conducted by USFDA, at the company's Oncology Parenteral and Oral Solids Dosage formulations facility at Malpur, Baddi, Himachal Pradesh.

Powered by Capital Market - Live News